Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
The Prostate
|
December 29, 2006
Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease
Michael W Shafer, Leslie Mangold, Alan W Partin, et al.
Scientific Reports
|
September 1, 2022
Urinary marker panels for aggressive prostate cancer detection
Tung-Shing Mamie Lih, Mingming Dong, Leslie Mangold, et al.
The Journal of Applied Laboratory Medicine
|
February 27, 2021
High "phi"ve
Lori J Sokoll, Leslie Mangold, Phaedre Mohr, et al.
Urology
|
February 19, 2008
Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Matthew E Nielsen, Danil V Makarov, Elizabeth Humphreys, et al.
BJU International
|
July 30, 2016
Role of biobanking in urology: a review
Heather J Chalfin, Elizabeth Fabian, Leslie Mangold, et al.
The Prostate
|
May 7, 2009
Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2
Eddy S Leman, Ahmed Magheli, Grant W Cannon, et al.
The Journal of Urology
|
July 4, 2006
Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center
Matthew E Nielsen, Misop Han, Leslie Mangold, et al.
Journal of Translational Autoimmunity
|
January 14, 2020
Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and <i>in vitro</i> studies of prostate cancer
Alka Jain, Haikoo Shah, Eleanor M Simonsick, et al.
Urology
|
December 22, 2015
Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men
Zeyad R Schwen, Jeffrey J Tosoian, Lori J Sokoll, et al.
Cancers
|
February 11, 2023
Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
Naseruddin Höti, Tung-Shing Lih, Mingming Dong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
The Prostate
|
December 29, 2006
Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease
Michael W Shafer, Leslie Mangold, Alan W Partin, et al.
Scientific Reports
|
September 1, 2022
Urinary marker panels for aggressive prostate cancer detection
Tung-Shing Mamie Lih, Mingming Dong, Leslie Mangold, et al.
The Journal of Applied Laboratory Medicine
|
February 27, 2021
High "phi"ve
Lori J Sokoll, Leslie Mangold, Phaedre Mohr, et al.
Urology
|
February 19, 2008
Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Matthew E Nielsen, Danil V Makarov, Elizabeth Humphreys, et al.
BJU International
|
July 30, 2016
Role of biobanking in urology: a review
Heather J Chalfin, Elizabeth Fabian, Leslie Mangold, et al.
The Prostate
|
May 7, 2009
Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2
Eddy S Leman, Ahmed Magheli, Grant W Cannon, et al.
The Journal of Urology
|
July 4, 2006
Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center
Matthew E Nielsen, Misop Han, Leslie Mangold, et al.
Journal of Translational Autoimmunity
|
January 14, 2020
Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and <i>in vitro</i> studies of prostate cancer
Alka Jain, Haikoo Shah, Eleanor M Simonsick, et al.
Urology
|
December 22, 2015
Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men
Zeyad R Schwen, Jeffrey J Tosoian, Lori J Sokoll, et al.
Cancers
|
February 11, 2023
Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
Naseruddin Höti, Tung-Shing Lih, Mingming Dong, et al.
Page
of 2